Top Markets
#1 Songbird Songbird +15.68%
#2 TENDIES TENDIES +9.42%
#3 DAPPOS DAPPOS +9.36%
#4 pipedog pipedog +8.37%
#5 Prom Prom +7.95%
#6 Helium Helium +7.35%
#7 Collector Crypt Collector Crypt +6.69%
#8 MarsCoin MarsCoin +6.62%
#9 Cryptopia Cryptopia +5.90%
#10 Moolah Moolah +5.25%
Coin of the day
Songbird Songbird
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Peringkat dalam Saham #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Harga Saham
$19.81
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$891.32M
Perubahan (1 hari)
1.39%
Perubahan (1 tahun)
5.16%
Negara
US
Perdagangan Beta Bionics, Inc. (BBNX)

Kategori

Healthcare
Riwayat dividen untuk Beta Bionics, Inc. (BBNX)
Saham Beta Bionics, Inc. (simbol: BBNX) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Beta Bionics, Inc. (BBNX) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00%
DE